Clinical Trial Update: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing preventive percutaneous coronary intervention (PCI) to medical therapy alone for vulnerable atherosclerotic coronary plaque.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease, Plaque, Atherosclerotic | Phase 4 | Status: COMPLETED